Co-Authors
This is a "connection" page, showing publications co-authored by DENISE NEBGEN and KAREN H LU.
Connection Strength
2.263
-
Bilateral salpingectomy with delayed oophorectomy for ovarian cancer risk reduction: A pilot study in women with BRCA1/2 mutations. Gynecol Oncol. 2018 07; 150(1):79-84.
Score: 0.633
-
Abnormal Uterine Bleeding as the Presenting Symptom of Hematologic Cancer. Obstet Gynecol. 2016 08; 128(2):357-363.
Score: 0.561
-
Remotely Delivered Cancer Genetic Testing in the Making Genetic Testing Accessible (MAGENTA) Trial: A Randomized Clinical Trial. JAMA Oncol. 2023 11 01; 9(11):1547-1555.
Score: 0.232
-
Novel Approaches to Ovarian Cancer Screening. Curr Oncol Rep. 2019 07 26; 21(8):75.
Score: 0.172
-
MAGENTA (Making Genetic testing accessible): a prospective randomized controlled trial comparing online genetic education and telephone genetic counseling for hereditary cancer genetic testing. BMC Cancer. 2019 Jul 02; 19(1):648.
Score: 0.172
-
Prospective Randomized Biomarker Study of Metformin and Lifestyle Intervention for Prevention in Obese Women at Increased Risk for Endometrial Cancer. Cancer Prev Res (Phila). 2018 08; 11(8):477-490.
Score: 0.158
-
Combined colonoscopy and endometrial biopsy cancer screening results in women with Lynch syndrome. Gynecol Oncol. 2014 Oct; 135(1):85-9.
Score: 0.122
-
Oncologic outcomes of incidental serous tubal intraepithelial carcinoma and associated high-grade serous carcinoma in high-risk patients undergoing risk-reducing surgery. Int J Gynecol Cancer. 2024 Nov 04.
Score: 0.062
-
An Accessible Communication System for Population-Based Genetic Testing: Development and Usability Study. JMIR Form Res. 2022 Oct 17; 6(10):e34055.
Score: 0.054
-
Using Social Media to Facilitate Communication About Women's Testing: Tool Validation Study. JMIR Form Res. 2022 Sep 26; 6(9):e35035.
Score: 0.054
-
Women's preferences for cancer risk management strategies in Lynch syndrome. Gynecol Oncol. 2019 03; 152(3):514-521.
Score: 0.042